Intraocular pressure screening clinic allows for continued management, including necessary changes in management
Virtual Kidney Transplant Evaluation Possible
Telehealth platform enabled maintenance of wait-list evaluation volume in large kidney transplant program during COVID-19 pandemic
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 4 to 8, 2021. This …
Biden Says He Will Release All Vaccine Doses After Taking Office
The potentially risky move is meant to boost a nationwide COVID-19 vaccination program that has gotten off to a slow start
Vaccine Rollout Slows as Many Health Care Workers Balk at Shots
In nursing homes and to some degree in hospitals, employees are refusing shots, expressing fears of side effects
Moderna COVID-19 Vaccine Protection May Last Years, Company Claims
CDC recommends people who have already had the virus also receive the vaccine as reinfection is possible
Perception of Not Returning to Full Health Common After COVID-19
47 percent experience fatigue, with no correlation between any measures of persistent disease and initial disease severity
HPV Treatment Demonstrates Positive Phase 2 Efficacy When Treating Precancerous Vulvar Dysplasia
A Pennsylvania based biotechnology company announced positive efficacy results for an open-label Phase 2 trial of VGX-3100 to treat HPV-16 and HPV-18-associated vulvar dysplasia.
A 25 percent or more reduction in HPV-16/18-associated vulvar HSIL (high-grade squamous intraepithelial lesion) was observed for 63 percent of trial participants (12 of 19) treated with VGX-3100 at six months post-treatment, stated INOVIO Pharmacuticals, Inc.’s press release issued on January 6, 2021.
WHO Grants Prequalification of Sabin-IPV Polio Vaccine
South Korean-based biotechnology company announced that its Sabin-Inactivated Polio Vaccine (Sabin-IPV) Eupolio™ is the first to receive the World Health Organization (WHO) prequalification be supplied globally.
LG Chem stated in a press release, ‘Eupolio demonstrated excellent phase III results in 2019, inducing high antibody titers against both wild-type and Sabin polioviruses, which will also protect against circulating vaccine-derived polioviruses (cVDPV) that make up the majority of polio cases in recent years.’
Majority of SARS-CoV-2 Transmission Due to Asymptomatic Individuals
In base case of modeling study, 59 percent of transmission attributed to presymptomatic and asymptomatic individuals